← FDA DRUG APPROVALS
FDA ANDA · ANDA212137
BRINZOLAMIDE; BRIMONIDINE TARTRATE
Sponsor: PERRIGO PHARMA INTERNATIONAL DAC
APPLICATION
ANDA212137
TYPE
ANDA
ROUTE
OPHTHALMIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
None (Tentative Approval)
Products
BRINZOLAMIDE; BRIMONIDINE TARTRATENone (Tentative Approval)
BRINZOLAMIDE 0.2MG,10MG, BRIMONIDINE TARTRATE · SUSPENSION/DROPS · OPHTHALMIC
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.